We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.6B
AUM Growth
+$129M
Cap. Flow
+$58.7M
Cap. Flow %
3.67%
Top 10 Hldgs %
25.88%
Holding
122
New
4
Increased
17
Reduced
39
Closed
1

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$29.8M
2
GS icon
Goldman Sachs
GS
+$19.9M
3
WFC icon
Wells Fargo
WFC
+$16.5M
4
ABBV icon
AbbVie
ABBV
+$15.2M
5
TFC icon
Truist Financial
TFC
+$14.5M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$23.7M
2
QCOM icon
Qualcomm
QCOM
+$20.1M
3
CVS icon
CVS Health
CVS
+$17.6M
4
VLO icon
Valero Energy
VLO
+$17M
5
ET icon
Energy Transfer Partners
ET
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.14%
2 Financials 14.05%
3 Real Estate 11.18%
4 Energy 10.09%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFC icon
51
Truist Financial
TFC
$63.2B
$15.6M 0.98%
277,400
+267,600
+2,731% +$14.5M
SBUX icon
52
Starbucks
SBUX
$118B
$14.7M 0.92%
166,900
SPY icon
53
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$14.6M 0.91%
45,366
-23,770
-34% -$7.32M
SJM icon
54
J.M. Smucker
SJM
$12.6B
$14.4M 0.9%
138,400
-300
-0.2% -$31.8K
PEG icon
55
Public Service Enterprise Group
PEG
$39.8B
$14M 0.88%
237,800
DD icon
56
DuPont de Nemours
DD
$18.6B
$13.6M 0.85%
168,655
-637
-0.4% -$52.9K
BA icon
57
Boeing
BA
$165B
$10.8M 0.67%
33,000
VGK icon
58
Vanguard FTSE Europe ETF
VGK
$30B
$7.69M 0.48%
+131,190
New +$7.33M
AGG icon
59
iShares Core US Aggregate Bond ETF
AGG
$138B
$7.59M 0.47%
67,570
-20
-0% -$2.25K
PM icon
60
Philip Morris
PM
$301B
$7.36M 0.46%
86,500
-287,600
-77% -$23.7M
HYG icon
61
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$5.28M 0.33%
+60,000
New +$5.22M
IJH icon
62
iShares Core S&P Mid-Cap ETF
IJH
$123B
$2.56M 0.16%
62,175
+275
+0.4% +$10.9K
IBM icon
63
IBM
IBM
$202B
$2.15M 0.13%
16,763
-419
-2% -$54.5K
GILD icon
64
Gilead Sciences
GILD
$161B
$1.27M 0.08%
19,600
-3,200
-14% -$208K
ET icon
65
Energy Transfer Partners
ET
$70.1B
$1.21M 0.08%
94,600
-1,287,808
-93% -$15.9M
TXN icon
66
Texas Instruments
TXN
$255B
$1.18M 0.07%
9,200
SUSB icon
67
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.29B
$1.01M 0.06%
39,900
CCL icon
68
Carnival Corporation Ltd
CCL
$36.1B
$884K 0.06%
17,400
-328,600
-95% -$14.7M
WMT icon
69
Walmart Inc
WMT
$871B
$502K 0.03%
12,660
AAPL icon
70
Apple
AAPL
$4.89T
$411K 0.03%
5,600
MCHP icon
71
Microchip Technology
MCHP
$42.8B
$408K 0.03%
7,800
AEE icon
72
Ameren
AEE
$31.5B
$399K 0.03%
5,200
BRK.A icon
73
Berkshire Hathaway Class A
BRK.A
$1.07T
$340K 0.02%
1
VNQ icon
74
Vanguard Real Estate ETF
VNQ
$39.9B
$315K 0.02%
3,400
CVX icon
75
Chevron
CVX
$388B
$307K 0.02%
2,550

Similar funds

Payden & Rygel's Q4 2019 Portfolio in Review

As of Q4 2019, Payden & Rygel held 122 positions worth $1.6B, up 8.8% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel deployed $58.7M of net new capital in Q4 2019, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was Conagra Brands: 1,027,000 shares worth $35.2M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was Philip Morris, an estimated $23.7M trimmed.

  • Payden & Rygel's largest Q4 2019 buy was Conagra Brands: 1,027,000 shares worth $35.2M.
  • Payden & Rygel added most to Goldman Sachs in Q4 2019, an estimated $19.9M increase.
  • Payden & Rygel's biggest Q4 2019 reduction was Philip Morris, cutting an estimated $23.7M.
  • Payden & Rygel fully exited ExxonMobil in Q4 2019, selling an estimated $60K.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.6B portfolio in Q4 2019.
  • Payden & Rygel opened 4 new positions and closed 1 in Q4 2019.
  • Payden & Rygel's portfolio value rose 8.8% quarter-over-quarter to $1.6B.

Based on Payden & Rygel's 13F filing for Q4 2019, filed 31 Jan 2020.